MedTrace Logo

Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

NCT01427569 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2015-12-24

No results posted yet for this study

Summary

The purpose of this study is to determine if topical application of a hydrogel that contains plant extracts will improve healing of diabetic foot ulcers when compared to treatment with a hydrogel alone.

Conditions

  • Diabetic Foot Ulcer

Interventions

DRUG

IZN-6D4 Gel

Standard wound therapy plus twice weekly topical application of hydrogel containing botanical extracts.

OTHER

Placebo hydrogel

Standard wound therapy plus twice weekly topical application of color-matched placebo hydrogel

Sponsors & Collaborators

  • Izun Pharma Ltd

    lead INDUSTRY

Principal Investigators

  • Gabriel Nussbaum, PhD, MD, · Izun Pharma Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01427569 on ClinicalTrials.gov